Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Arista · 1 trial · 1 indication
Calculated on standard hospital protocol
| Arm | Type | Description |
|---|---|---|
| Arista group | EXPERIMENTAL | this group of randomized patients will receive 5 grams of arista hemostatic powder intra-operatively in their wound in addition to 1 gram of IV transexemic acid prior to incision |
| control group | NO_INTERVENTION | this group of randomized patients will receive just the 1 gram of IV transexemic acid prior to incision |
| Name | Type | Description |
|---|---|---|
| Arista | DRUG | hemostatic powder |
Inclusion Criteria: * • They willingly desire to participate and signed the informed consent * Are between the ages of 18 and 100 years of age * Have the mental capacity to provide consent * Are undergoing a primary unilateral total knee arthroplasty Exclusion Criteria: * • allergy to Aris...
Arista is a small molecule drug being developed for surgical blood loss. It is currently in Phase 1 clinical development as an investigational therapy. The drug is intended to address blood loss that occurs during surgical procedures.
Arista is being developed by Becton, Dickinson and Company, a company traded on the New York Stock Exchange under the ticker symbol BDX. The company is conducting clinical research to evaluate the drug's safety and efficacy in surgical settings.
Arista is in Phase 1 clinical development. It is an investigational drug and has not yet been approved by regulatory authorities. The drug is being studied for its potential to manage surgical blood loss, with one clinical trial completed to date.
Arista has been studied in one clinical trial registered as NCT05522153, titled "Arista Hemostatic Powder for Total Knee Post Operative Outcomes Study." This Phase 1 trial was completed in the United States and enrolled 61 participants, including healthy volunteers aged 18 years and older.
Yes, Arista is also known as Arista Hemostatic Powder, as referenced in the clinical trial title. The drug is being evaluated for its hemostatic properties, which relate to controlling bleeding, specifically in the context of surgical procedures.